China’s Covid spike weighs on Asia markets
On Friday, US equities limped into a non-descript finish to the week as inflation fears were compounded by growth fears, notably from China. The S&P 500 fell 0.27%, the Nasdaq tumbled by 1.34%, while the Dow Jones booked a 0.40% gain as investors rotated into value for the weekend. Those same China fears, as the omicron situation darkened there over the weekend, have sent futures on all three major indexes over 0.55% lower in Asian trading.
A similar story is playing out across Asia today, compounded by China’s property developer nerves. The Nikkei 225 fell 0.75%, and South Korea’s Kospi eased 0.35% lower. Mainland China markets are under heavy pressure, the Shanghai Composite tumbling by 1.75%, with the CSI 300 in full retreat, falling by 2.35%. Hong Kong has also taken fright, the Hang Seng dropping by 2.40%.
In regional markets, Singapore is 0.65% lower, Kuala Lumpur is rather surprisingly, unchanged, and Jakarta has climbed 0.65%. The rally in Jakarta has been driven by GoTo’s IPO commencing trading, with its stock climbing 23% on debut. Elsewhere, Bangkok is down 0.45%, and Manila is 0.10% lower. The rise in platinum group metals prices seems to be providing some support to Australian markets, with the ASX 200 and All Ordinaries unchanged. However, the prospect of multiple 0.50% RBNZ rate hikes, starting this week, has sent the NZX 50 0.90% lower.
Nothing around Eastern Europe or the French presidential election will give European equities anything to cheer about this afternoon. Nor will the upcoming ECB meeting with lower risks of hiking offset by what is likely to be darkening growth projections from the ECB.
This article is for general information purposes only. It is not investment advice or a solution to buy or sell securities. Opinions are the authors; not necessarily that of OANDA Corporation or any of its affiliates, subsidiaries, officers or directors. Leveraged trading is high risk and not suitable for all. You could lose all of your deposited funds.